Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed)
Funding Opportunities
Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed)
RFA-AI-24-025
NIH
Letter of Intent Deadline: Sep 09 2024
Funding Opportunity Purpose
The purpose of this Notice of Funding Opportunity (NOFO) is to support basic and applied research to understand and improve durable immune responses to candidate HIV vaccines.